<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03610126</url>
  </required_header>
  <id_info>
    <org_study_id>IRB: 17300212</org_study_id>
    <nct_id>NCT03610126</nct_id>
  </id_info>
  <brief_title>BASKA Laryngeal Mask Airway in Either Volume or Pressure Controlled Ventilation in Laparoscopic Cholecystectomy</brief_title>
  <official_title>Comparison of Efficacy of BASKA Laryngeal Mask Airway in Either Volume or Pressure Controlled Ventilation in Laparoscopic Cholecystectomy Comparative Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study will be undertaken to compare the efficacy of BASKA mask in volume controlled and
      pressure controlled ventilation in laparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic cholecystectomy is one of the most commonly performed surgical procedures and
      the laryngeal mask airway (LMA) is the most common supraglottic airway device used by the
      anesthesiologists to manage airway during general anesthesia. Use of LMA has some advantages
      when compared to endotracheal intubation, such as quick and ease of placement, a lesser
      requirement for neuromuscular blockade and a lower incidence of postoperative morbidity.
      However, the use of the LMA in laparoscopy is controversial, based on a concern about
      increased risk of regurgitation and pulmonary aspiration. The ability of these devices to
      provide optimal ventilation during laparoscopic procedures has been also questioned. The most
      important parameter to secure an adequate ventilation and oxygenation for the LMA under
      pneumoperitoneum condition is its seal pressure of airway The BASKA mask is a novel
      supraglottic airway device. It has many of the features of other supraglottic airways, These
      include; A non-inflatable cuff, that it is continuous with the central channel of the device.
      As the pressure increases with positive pressure ventilation, the cuff itself is 'inflated',
      this may improve the seal, reduce leak, and make ventilation more efficient
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 26, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>oropharyngeal leak pressure</measure>
    <time_frame>Intra-operative</time_frame>
    <description>the oropharyngeal leak airway pressure will be used as a primary outcome to compare the efficacy of BASKA mask in volume controlled and pressure controlled ventilation in laparoscopic cholecystectomy and measuring leak pressure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>End tidal carbon dioxide</measure>
    <time_frame>Intraoperative</time_frame>
    <description>End tidal carbon dioxide measurement to determine efficacy of ventilation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Ventilation</condition>
  <arm_group>
    <arm_group_label>volume controlled ventilation</arm_group_label>
    <description>after induction of anesthesia and insertion of BASKA laryngeal mask airway mechanical ventilation of patients will be maintained with volume controlled ventilation mode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pressure controlled ventilation</arm_group_label>
    <description>after induction of anesthesia and insertion of BASKA laryngeal mask airway and mechanical ventilation of patients will be maintained with pressure controlled ventilation mode</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>volume controlled ventilation</intervention_name>
    <description>the patients will be ventilated by volume controlled ventilation after insertion of the BASKA laryngeal mask airway</description>
    <arm_group_label>volume controlled ventilation</arm_group_label>
    <other_name>volume controlled</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pressure controlled ventilation</intervention_name>
    <description>the patients will be ventilated by pressure controlled ventilation after insertion of the BASKA laryngeal mask airway</description>
    <arm_group_label>pressure controlled ventilation</arm_group_label>
    <other_name>pressure controlled</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ASA I&amp;II in the age range 20-60 years of both sexes and scheduled for elective laparoscopic
        cholecystectomy surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for elective cholecystectomy laparoscopic surgery.

          -  Age: 20-60 years.

          -  ASA physical status: I-II.

        Exclusion Criteria:

          -  Patient refusal.

          -  History of cardiac disease, psychological disorders, respiratory diseases including
             asthma, renal or hepatic failure.

          -  Patients who have high risk of regurgitation or aspiration based on history of gastro
             esophageal reflux, hiatus hernia, diabetes and gross obesity.

          -  Neck pathology.

          -  Patients who predicted difficult airway (based on a history of difficult airway, mouth
             opening was less than 2.5 cm, inter-incisor distance &lt; 20 mm, cervical spine
             pathology, modified Mallampati class III/IV, or thyromental distance &lt; 65 mm).

          -  Preoperative sore throat.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hala S Abdel-Ghaffar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut university hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hala S Abdel-Ghaffar, MD</last_name>
    <phone>+2 01003812011</phone>
    <email>hallasaad@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>amani abd elwahab, MD</last_name>
    <phone>01004610623</phone>
    <email>amanihassan1978@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university hospitals</name>
      <address>
        <city>Assiut</city>
        <state>Assiut Governorate</state>
        <zip>Egypt,71571</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala S Abdel-Ghaffar, MD</last_name>
      <phone>+01003812011</phone>
      <email>hallasaad@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Amani Hassan abdel-wahab, MD</last_name>
      <phone>+01004610623</phone>
      <email>amanihassan1976@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 16, 2018</study_first_submitted>
  <study_first_submitted_qc>July 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Hala Saad Abdel-Ghaffar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>BASKA mask</keyword>
  <keyword>controlled ventilation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

